ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Ambrisentan OrPha:OrPha Swiss GmbH
Complete information for professionalsDDDPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 

Zusammensetzung

Wirkstoffe
Ambrisentanum.
Hilfsstoffe
Ambrisentan OrPha 5 mg: Cellulosum microcristallinum, Lactosum monohydricum (47.5 mg), Carmellosum natricum conexum, Magnesii stearas, Poly(alcohol vinylicus) (E 1203), Titanii dioxidum (E 171), Macrogolum 3350 (E 1521), Talcum, Rubrum allura AC (E 129; 0.022 mg), Soja Lecithinum (E 322).
1 Filmtablette enthält 0.16 mg Natrium.
Ambrisentan OrPha 10 mg: Cellulosum microcristallinum, Lactosum monohydricum (95 mg), Carmellosum natricum conexum, Magnesii stearas, Poly(alcohol vinylicus) (E 1203), Titanii dioxidum (E 171), Macrogolum 3350 (E 1521), Talcum, Rubrum allura AC (E 129; 0.405 mg), Soja Lecithinum (E 322).
1 Filmtablette enthält 0.35 mg Natrium.

2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home